|drug487||Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group Wiki||1.00|
|drug488||Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) high-dose group Wiki||1.00|
|drug489||Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) placebo group Wiki||1.00|
There is one clinical trial.
Stigma around abortion and other reproductive health care is pervasive in most contexts and has been documented to have implications for the quality of care. This study aims to assess how Values Clarification and Attitude Transformation (VCAT) workshops for providers of abortion and family planning services influences service provision of abortion and family planning services, including the quality and person-centeredness of care provided. A secondary aim is to measure how provider attitudes, knowledge, and behavioral intent change over time as a result of the VCAT workshop.This study will be conducted across multiple regions in Ethiopia.
Description: A validated scale measuring the dimensions of respectful and supportive care, communication and autonomy, and structural quality. The score is on a scale from 0 to 69 and higher scores represent more person-centered care.Measure: Person-centered abortion and family planning scale Time: 1.5 months
Description: Percent of clients reporting having received kind and compassionate care from their provider, not feeling like they were treated differently based on age, marital status, or other characteristic, not feeling judged by their provider, having received respectful care, and feeling involved in the decisions around their careMeasure: Percent of clients reporting essential person-centered care components Time: 1.5 months
Description: Proportion knowing the legal indications for abortion in Ethiopia, the legal grounds for denial of abortion services, and the correct interpretation of the law around abortion services for married women, minors, women seeking services under the rape and incest clause, and women requesting an abortion under the grounds that the pregnancy is a risk to their healthMeasure: Level of knowledge around interpretation for legal grounds for abortion in Ethiopia Time: 6 months
Description: Volume of abortion and family planning clients under age 20Measure: Volume of patients Time: 1 year
Description: Number of referrals for safe abortion care and for family planning among clients under the age of 20Measure: Patient referrals by promoters Time: 1 year
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports